Type of Medication Therapy for ADHD and Stimulant Misuse during Adolescence
Date
2023-04
Authors
Schepis, Ty S.
Werner, Kennedy
Figueroa, Olivia
McCabe, Vita V.
Schulenberg, John
Veliz, Philip T.
Wilens, Timothy E.
McCabe, Sean Esteban
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Adolescent attention-deficit/hyperactivity disorder (ADHD) diagnosis rates increased from 18% to 33% in the USA from 1999 to 2016. Fairman et al. found a 15.6% increase in stimulant prescribing to youth from 2008/09 to 2012/13, and nonstimulant prescribing is 10-15% of all therapy. Attention-deficit/hyperactivity disorder (ADHD) is associated with higher substance use rates, including prescription stimulant misuse (PSM), cocaine use, and methamphetamine use. Stimulant and non-stimulant pharmacotherapy improve adolescent ADHD, but their associations with PSM, cocaine, and methamphetamine use are unclear. Using 2005–2020 US Monitoring the Future (MTF) data, we investigated relationships between ADHD pharmacotherapy history and PSM, cocaine, or methamphetamine use.
Description
Keywords
medication therapy, stimulant misuse, adolescent attention-deficit hyperactivity disorder, ADHD
Citation
Schepis, T. S., Werner, K. S., Figueroa, O., McCabe, V. V., Schulenberg, J. E., Veliz, P. T., Wilens, T. E., & McCabe, S. E. (2023). Type of medication therapy for ADHD and stimulant misuse during adolescence. Poster presented at the Health Scholar Showcase, Translational Health Research Center, San Marcos, Texas.